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Introduction 
E. longifolia Jack belongs to the 
Simaroubaceae family and is abundant in 
South East. From the roots of E. longifolia 
Jack, used as a folk medicine, a highly 
oxygenated quassinoid, named eurycomanone 
was isolated. Eurycomanone, a C20 quassinoid 
is a cytotoxic bioactive ingredient found in E. 
longifolia Jack with a molecular formula of 
C20H24O9 (Chan et al., 1986) and was isolated 
as white cubic crystals. Eurycomanone 
demonstrated a general cytotoxic response 
with all of the epithelial cell types: KB, 
vincristine resistant KB (KB-VI), 
fibrosarcoma, melanoma, lung cancer, colon 
cancer and breast cancer cell lines. In 
addition, the most intense response was 
observed with the fibrosarcoma cell line, 
implying selectivity. Eurycomanone has 
demonstrated significant antimalarial activity 
as judged by studies conducted with on 
cultured Plasmodium falciparum strain (Chan 
et al., 1986; Kardono et al., 1991).  
In the present study, we tested semi-
purified eurycomanone induced apoptotic 
activity and examined the effects of semi-
purified eurycomanone on BCL-2 family 
proteins, caspases and caspases targeted 
proteins in MCF-7 breast cancer cells.  
 
Materials and Methods 
 
Cell culture  
MCF-7 and MCF-10A cells were obtained 
from the American Type Culture Collection 
(ATCC, USA). MCF-7 cells was cultured in 
Dulbecco’s Modified Eagle’s medium (Gibco 
BRL) was supplemented with 5% fetal bovine 
serum and penicillin-streptomycin, fungizon 
and gentamycin. Whereas, MCF-10A cells 
were maintained in MEGM (Clonetics) 
supplemented with 100 ng/ml Cholera toxin.  
 
Cell proliferation assay 
Semi-purified eurycomanone was isolated 
from the roots of E. longifolia Jack, as 
previously described (Darise et al. 1982).  
 
MCF-7 cells were seeded into 96 well plates 
at an initial cell density of approx. 1 X 105 
cells/ml. After an overnight incubation for cell 
attachment, the medium was removed and 
replaced with fresh medium. Semi-purified 
eurycomanone was first dissolved in DMSO 
and the cells were treated at increasing 
concentrations to evaluate its in vitro 
antiproliferative activity. Control wells 
received only DMSO. The assay was 
terminated on day 4. Cell survival on day 4 
was determined by the procedure using 
methylene blue as described by Lin & Hwang 
(1991). Cell viability was determined at 660 
nm employing the ELISA reader. EC50 values 
were then calculated from the graph plotted 
for percentage of viable cells (%) versus log 
concentration (mg/ml) of each test. 
 
TUNEL assay  
Cells were grown on slides in petri dishes 
and treated with semi-purified eurycomanone, 
DMSO and tamoxifen respectively and 
incubated overnight. DNA fragmentation that 
is characteristic of apoptotic cells was 
quantified by Tdt-mediated dUTP nick end 
labeling (TUNEL) with the Apoptosis 
Detection Kit, Fluorescein (Promega) 
according to the manufacturer’s instruction. 
Cells were observed under the fluorescence 
microscope at 520nm. To calculate the 
percentage of TUNEL positive cells, we 
counted all of the cells from four random 
microscopic fields at x1000 magnifications. 
 
Western blotting analysis 
20µg of protein from both the treated and 
untreated cells were size fractionated under 
denaturing conditions on 12 % SDS-
polyacrylamide gels. After electrophoresis, the 
resolved proteins were transferred onto 
polivynyl-difluoride membranes (Nen Life 
Science). The membranes were dried, 
preblocked with 5% non-fat milk in 
phosphate-buggered saline and 0.1% Tween-
20, then incubated with a primary antibody 
with either anti-BAX monoclonal, BCL-2, 
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caspase-6, 7, 8, 9; BID, FADD, Lamin and 
anti-PARP monoclonal (1: 2000 dilution; 
PharMingen) antibodies for 2 h at room 
temperature. This was followed by incubation 
with anti-mouse (1:30, 000 dilution) IgG 
conjugated with horseradish peroxidase. 
Probed immunoreactive protein bands were 
visualized with ECL (Nen Life Science). 
Following exposure on a Kodak OMAT x-ray 
film. Protein bands were quantified by 
densitometry analysis was performed with GS 
670 Imaging Densitimeter with the Molecular 
Analyst Software (BioRad, Hercules, USA). 
 
Results and Discussion 
 
Antiproliferative assay 
According to the National Cancer Institute 
in United States of America, plant extract that 
confer cytotoxicity at EC50 value exceeding 20 
µg/ml can be categorized as a anticancer or 
cytotoxic potential (Wall et al., 1987). In these 
studies we attempted to determine the effect 
of semi-purified eurycomanone on the growth 
of cancerous mammary cells, MCF-7 and non-
cancerous breast cells, MCF-10A. Tamoxifen 
was used on these cells lines for positive 
control. 
EC50 value of semi-purified eurycomanone 
and tamoxifen on MCF-7 cell is 2.2±0.18 
µg/ml and 4.79±0.04 µg/ml respectively 
(Figure 1). These findings suggest that semi-
purified eurycomanone as a potential 
antiproliferative agent on MCF-7 cells since 
the EC50 value is less than 20 µg/ml. The 
antiproliferative activity of semi-purified 
eurycomanone in this research is effective on 
MCF-7 cancer cells and this is in concert with 
the results obtained with pure eurycomanone 
(EC50 1.1 µg/ml) on mammary cancer cells 
(Kardono et al., 1991). Some biological 
researchers show that certain chemical 
compounds from E. longifolia Jack have 
significant biological activity. For example, 
quassinoids were reported to have anticancer 
activity (Kardono et al., 1991). Tamoxifen 
imposed an inhibitory effect on estrogen 
receptor positive MCF-7 cells with an EC50 
value of 4.79±0.04 µg/ml. Tamoxifen is 
effective towards MCF-7 cells because of its 
antiestrogenic properties (Lippman & Huff, 
1986). Tamoxifen interacts directly with the 
estrogen receptor and forms an inactive 
complex (Rochefort et al., 1983) thus 
disabling estrogen from binding estrogen 
positive tumor cells. These complexes prevent 
cancerous cells from entering G1 phase in cell 
cycle (Jordon et al., 1980). Therefore, the 
population of the cancer cells diminishes. 
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FIGURE 1 Antiproliferative effects of the semi-
purified eurycomanone and tamoxifen on 
cancerous breast cells (MCF-7). EC50 values are 
2.2±0.18 and 4.79±0.04 µg/ml respectively. 
 
EC50 value of semi-purified eurycomanone 
and tamoxifen on MCF-10A cell is 
30.90±0.99 µg/ml and 2.59±0.11 µg/ml 
respectively (Figure 2). Cytotoxicity test 
conducted on MCF-10A using semi-purified 
eurycomanone; a high EC50 value exceeding 
20 µg/ml was obtained, 30.90±0.99 µg/ml and 
this showed that semi-purified eurycomanone 
is cytoselective towards cancerous cells but 
does inhibit the proliferation of MCF-10A 
cells. Tamoxifen, however disposed strong 
inhibitory effects which inhibits the 
proliferation of MCF-10A cells. Tamoxifen is 
not a selective anticancer drug since it 
inhibited the proliferation of both non-
cancerous cells (EC50 = 2.59 ± 0.1 µg/ml) and 
cancerous cells (EC50 = 4.79 ± 0.04 µg/ml) at 
low concentrations.  
The 4th Annual Seminar of National Science Fellowship 2004
14
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
150
160
-1-1.3-1.6-1.9-2.2-2.5-2.8-3.1-3.4
Log concentration (mg/ml)
V
ia
bl
e 
ce
lls
 (%
)
Eurycomanone Tamoxifen
 
FIGURE 2 Antiproliferative effects of the semi-
purified eurycomanone and tamoxifen on non-
cancerous breast cells (MCF-10A). EC50 values are 
30.90±0.99 and 2.59±0.11 µg/ml respectively. 
 
In cancer treatment, tumour cell loss may 
be contributed to a high frequency of 
apoptosis due to the effect of anticancer 
agents (Kerr et al., 1994) and the 
antiproliferative activity shown by semi-
purified eurycomanone could possibly be due 
to the induction of apoptosis. To test this 
hypothesis, methods detecting different end-
points of apoptosis were employed.  
 
TUNEL assay 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3 TUNEL Assay: MCF-7 cells treated 
with A) DNase 1 (positive control), B) DMSO 
(negative control), C) semi-purified eurycomanone 
at 2.5 µg/ml and D) Tamoxifen at 4.8 µg/ml at 24 
hours.  
 
A set of characteristic changes that make 
apoptotic cell death readily identifiable: cells 
shrinkage; chromatin condensation; 
membranes blebbing and nuclear 
fragmentation. The morphological changes in 
apoptosis have been extensively reviewed 
elsewhere (Wyllie et al. 1980). Figure 3 shows 
nuclear DNA fragmentation, a hallmark of 
apoptosis. In the positive control which was 
treated with DNase 1, 100% of MCF-7 cells 
underwent apoptosis (Figure 3a) and almost 
all nuclei of MCF-7 were seen to be 
fluorescent. Negative control using DMSO (< 
1%) showed little fluorescense in the nucleus 
(Figure 3b). DMSO by itself does not cause 
cells to undergo apoptosis. Hence, apoptosis 
signal is less due to less DNA fragmentation 
and less fluorescent TdT-binding to DNA. 
MCF-7 cells treated with eurycomanone at 2.5 
µg/ml (Figure 3c) showed extensive apoptosis 
activity whereby intense fluorescence was 
seen in nuclei of cells undergoing DNA 
fragmentation. Cells treated with semi-
purified eurycomanone were proven to induce 
apoptosis in MCF-7 cells. Previous reports 
have suggested that Tamoxifen induced 
characteristic morphological changes 
consistent with apoptosis, including 
condensation of cytoplasm and convolution of 
nuclear and internucleosomal DNA 
fragmentation in breast cancer cells. 
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FIGURE 4 Semi-purified eurycomanone treatment 
(2.5 µg/ml) significantly increased the level of 
apoptosis in MCF-7 cells in contrast to untreated 
controls. Results are presented as the mean ± SD 
of 3 independent experiments. 
To confirm whether semi-purified 
eurycomanone-treated cells underwent death 
via apoptosis; the extent of DNA 
fragmentation was analyzed in a time-course 
manner. When MCF-7 cells were treated with 
2.5 µg/ml of eurycomanone, TUNEL-positive 
cells were first detected at 24 hours of 
treatment with >70% of cells score as 
apoptotic, and this number increased to >80% 
A) 
C) D) 
B) 
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by 48 hours, and then to >85% at 72 hours of 
eurycomanone treatment. Untreated control 
cells only recorded <5% apoptotic cells. When 
treated with semi-purified eurycomanone for 
72 h, the cells exhibited a 8-fold higher 
apoptosis rate than untreated cells (P < 0.001). 
Eurycomanone treatment significantly 
increased the level of apoptosis of MCF-7 
cells in contrast to untreated controls. 
Cancer cell death via apoptosis has been 
discerned in chemotherapeutic treatment of 
cancerous cells. Chemotherapeutic drug that 
can induce apoptosis in cancerous cell are 
tamoxifen, taxol and meltafan (Thompson 
1995). The precise nature of the death 
pathway silenced by semi-purified 
eurycomanone still needs to be studied.  
 
Effects of semi-purified eurycomanone on 
the BCL-2 and BAX proteins expression 
To determine the effects of semi-purified 
eurycomanone on the expression of BCL-2 
and BAX proteins in MCF-7 cells, we 
performed Western blotting analysis was 
performed. BCL-2 protein expression 
decreased as early as 2 hours following semi-
purified eurycomanone treatment, while BAX 
levels were not altered and remained low 
throughout the experiment. 2.5 µg/ml of semi-
purified eurycomanone caused 55% reduction 
in BCL-2 protein expression following 24 
hours of treatment compared with non-treated 
cells (Figure 5B). Semi-purified 
eurycomanone down-regulated BCL-2 protein 
levels in a time-dependent manner (Figure 
5B). Furthermore, this down-regulation in 
BCL-2 protein correlated with apoptosis 
detected by TUNEL assay (Figure 3). These 
observations suggest that down-regulation of 
BCL-2 plays a critical role in deregulation of 
apoptosis inhibition and also triggers 
apoptosis by eurycomanone.  
We determined the effects of semi-purified 
eurycomanone on p53 protein expression by 
Western blotting analysis. No differences in 
p53 protein levels were found between 
untreated cells and those treated with 2.5 
µg/ml for up to 24 h (data not shown).  
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FIGURE 5 Effects of eurycomanone on BCL-2 
and BAX protein in MCF-7 cells. (A) MCF-7 cells 
were treated with semi-purified eurycomanone at 
the concentrations 2.5 µg/ml for up to 24 hours. 
(B) Eurycomanone-induced BCL-2 and BAX 
protein expression decreased in a time-dependent 
manner as seen in Western Blot. BCL-2 and BAX 
bands were quantified using Imaging Densitimeter. 
Data are shown as the means of three separate 
experiments; bars, SD. 
 
 
Effects of semi-purified eurycomanone on 
the expression of caspases  
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FIGURE 6 Following semi-purified eurycomanone 
(2.5 µg/ml) treatment on MCF-7 cells, the caspase-
6 pro-enzyme (34 kDa), caspase-7 pro-enzyme (35 
kDa), caspase-8 pro-enzyme (50 kDa) and caspase-
9 pro-enzyme (49 kDa) was cleaved.  
 
Caspases, a family of cysteine proteases, 
play a critical role in the execution phase of 
apoptosis and are responsible for many of the 
biochemical and morphological changes 
associated with apoptosis. It has been 
proposed that “initiator” caspases, such as 
caspase-8 and -9 either directly or indirectly 
activates “effector” caspases, such as 
caspases-6, and -7. Semi-purified 
eurycomanone caused reduction in 
A) 
BCL-2
BAX
CASPASE-6 
CASPASE-7
CASPASE-8
CASPASE-9
B) 
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procaspase-8 protein expression after 24 hours 
of treatment compared with non-treated cells. 
These observations suggest that active 
caspase-8 which is the cleaved product of 
procaspase-8 plays a critical role in triggering 
the apoptotic machinery via the death 
pathway. 
 
Effects of semi-purified eurycomanone on 
BID and FADD proteins expression 
     
    0       2      4       6     12     24   hours 
 
 
 
 
FIGURE 7 Following semi-purified eurycomanone 
treatment on MCF-7 cells (2.5 µg/ml), the Bid (23 
kDa) was cleaved generating a catalytically active 
tBid and the FADD (24 kDa) was being express. 
 
To establish that caspase-8 was being 
activated, the cleavage of the caspase-8 
substrate Bid was examined by immunoblot. 
Caspase-8 cleaves and activates effector 
caspases but also processes the Bcl-2 family 
member Bid to generate a proapoptotic 
fragment termed truncated Bid (tBid). tBid 
translocates to mitochondria, inserts in the 
outer membrane, and, in cooperation with Bax 
or Bak, brings about Cytochrome c release.  
Caspase-8 is a 55 kDa cytosolic protein 
with homology to the CD95/Fas-associated 
signal transducer, FADD. FADD therefore 
acts as an adapter molecule, allowing caspase-
8 to become recruited to the cytoplasmic 
region of Fas following receptor activation.  
 
Effects of semi-purified eurycomanone on 
the expression of caspases-targeted proteins  
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FIGURE 8 Following semi-purified eurycomanone 
(2.5 µg/ml) treatment on MCF-7 cells, the lamin 
(74 kDa) was cleaved generating a catalytically 
active 65-kDa fragment of lamin and the PARP 
(116 kDa) was cleaved. 
Caspases have been recognized as the 
central executioners of apoptosis. Once 
activated, effector caspases target cellular 
proteins for proteolysis, leading eventually to 
cell death. Caspase-6, appears to cleave only 
the nuclear lamins during apoptosis. Lamin is 
an important nuclear membrane protein in 
maintaining normal cell functions such as cell 
cycle control, DNA replication and chromatin 
organization. Lamin serves as a marker for 
caspase-6 activation. The cleavage of lamins 
results in nuclear disregulation and cell death. 
PARP is a target of the caspase protease 
activity (caspase-7) associated with apoptosis. 
During apoptosis, PARP is cleaved from its 
proform of 116 kDa. On the other hand, 
PARP is always cleaved by a caspase 
regardless of the death stimulus or cell type. 
PARP cleavage is believed to attenuate its 
ability to carry out DNA repair and so hastens 
apoptosis  
In a nutshell, semi-purified eurycomanone 
of E. longifolia Jack displays cytoselectivity 
which inhibits the growth of cancerous cells, 
MCF-7 with an EC50 value 2.2 µg/ml but not 
non-cancerous cells, MCF-10A. The 
antiproliferative effect of semi-purified 
eurycomanone on MCF-7 cells was depicted 
via apoptotic cell death. Semi-purified 
eurycomanone treatment resulted in apoptotic 
cell death of MCF-7 breast cancer cells 
involving down-regulation of BCL-2; 
activation of caspases-6, 7, 8 and 9 leading to 
activation of tBID and FADD followed by 
cleavage of PARP and Lamin. 
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